BriaCell Therapeutics Corp.
BCTX
$3.46
-$0.19-5.21%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 571.88% | -7.87% | -85.02% | -54.24% | -35.79% |
| Total Receivables | 229.55% | 4,744.74% | -49.50% | 40.65% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -55.11% | -16.25% | 15.33% | -16.79% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 124.94% | -33.93% | -52.90% | -36.21% | -31.69% |
|
|
|||||
| Total Current Assets | 124.94% | -33.93% | -52.90% | -36.21% | -31.69% |
| Net Property, Plant & Equipment | -5.90% | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -1.90% | -1.87% | -1.83% | -1.85% | -1.77% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.00% | -- | -- | -- | -- |
| Total Assets | 77.35% | -5.34% | -49.28% | -34.31% | -31.46% |
|
|
|||||
| Total Accounts Payable | -40.95% | 11.65% | 73.04% | 755.38% | -61.39% |
| Total Accrued Expenses | 159.88% | -13.42% | 57.54% | -65.25% | -9.61% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -33.14% | 10.41% | 72.20% | 274.99% | -41.91% |
|
|
|||||
| Total Current Liabilities | -33.14% | 10.41% | 72.20% | 274.99% | -41.91% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 56.27% | -80.70% | -65.84% | 10.41% | -48.33% |
| Total Liabilities | -21.69% | -31.19% | -39.48% | 27.61% | -47.96% |
|
|
|||||
| Common Stock & APIC | 13.68% | 3.70% | 0.00% | -10.22% | 11.38% |
| Retained Earnings | -6.79% | -1.44% | 2.00% | -15.13% | 7.44% |
| Treasury Stock & Other | 21.60% | 25.62% | 4.74% | 6,070.08% | -101.90% |
| Total Common Equity | 269.69% | 60.06% | 26.11% | -396.65% | 172.05% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 269.69% | 60.06% | 26.11% | -396.65% | 172.05% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -8.96% | -12.92% | -9.62% | -19.16% | -- |
| Total Equity | 238.29% | 56.92% | 25.06% | -430.54% | 166.62% |
|
|
|||||
